Disease State Insights

In order to effectively market products into payer channels, drug manufacturers need to fully understand the environment of the category in which their products will compete. The dynamics of a specific category have a unique profile in terms of cost sensitivity, competitive landscape, unmet needs and barriers to reimbursement. These factors are fluid and change over time.

Disease State Insights provides an up to date detailed overview of a particular disease state, its treatment options, and economics within the various payer channels. Disease State Insights employs a blend of secondary market research to identify key market trends together with primary market research with payer executives and physicians to identify decision maker attitudes towards current treatments and manufacturers. This service is applicable to both marketed and pipeline products. Find out how well your product's value proposition fits the needs of specific payer channels.

Disease State Insights is specifically geared towards providing payer insights to the disease state and provides important information to:
• VP Marketing/VP Managed Markets
• Brand managers
• Managed markets marketing
• Market researchers with payer responsibility
• Account management leadership
• Commercialization managers and new product planning

Disease State Insights is published twice each year and consists of approximately 75 PowerPoint slides. See the reverse side for a typical report table of contents.

Sample Table of Contents
• Executive summary
• Market & payer events over prior 6 months
• Ongoing disease state trends
• Burden of disease state to payers
• Key competitors: Strengths and weaknesses
• Unmet payer needs
• Clinical factors
• Economic factors
• Cost sensitivity thresholds
• Key decision makers
• Manufacturer assessments
• Manufacturer positioning, messages and services
• Barriers to physician prescribing/utilization
• Barriers to patient utilization